Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2004-08-16
2008-10-07
Helms, Larry R. (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007230, C530S387100, C530S387700
Reexamination Certificate
active
07432064
ABSTRACT:
The present invention provides new methods for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating prostate cancer.
REFERENCES:
patent: 5514579 (1996-05-01), O'Hara et al.
patent: 5952011 (1999-09-01), O'Hara et al.
patent: 6043033 (2000-03-01), Bandman et al.
patent: 6203979 (2001-03-01), Bandman et al.
patent: 6262245 (2001-07-01), Xu et al.
patent: 6294663 (2001-09-01), O'Brien et al.
patent: 6350448 (2002-02-01), Bandman et al.
patent: 1033401 (2000-09-01), None
patent: 11032768 (1999-02-01), None
patent: WO 93/13207 (1993-07-01), None
patent: WO 98/20165 (1998-05-01), None
patent: WO 98/36054 (1998-08-01), None
patent: WO 98/37093 (1998-08-01), None
patent: WO 98/37418 (1998-08-01), None
patent: WO 98/45435 (1998-10-01), None
patent: WO 99/06548 (1999-02-01), None
patent: WO 99/14328 (1999-03-01), None
patent: WO 99/36550 (1999-07-01), None
patent: WO 99/37811 (1999-07-01), None
patent: WO 99/57132 (1999-11-01), None
patent: WO 99/60162 (1999-11-01), None
patent: WO 99/62941 (1999-12-01), None
patent: WO 99/62942 (1999-12-01), None
patent: WO 99/67384 (1999-12-01), None
patent: WO 00/00605 (2000-01-01), None
patent: WO 00/04149 (2000-01-01), None
patent: WO 00/12706 (2000-03-01), None
patent: WO 00/12758 (2000-03-01), None
patent: WO 00/14234 (2000-03-01), None
patent: WO 00/16805 (2000-03-01), None
patent: WO 00/18961 (2000-04-01), None
patent: WO 00/23111 (2000-04-01), None
patent: WO 00/29448 (2000-05-01), None
patent: WO 00/36107 (2000-06-01), None
patent: WO 00/43495 (2000-07-01), None
patent: WO 00/55351 (2000-09-01), None
patent: WO 00/55629 (2000-09-01), None
patent: WO 00/73454 (2000-12-01), None
patent: WO 00/76531 (2000-12-01), None
patent: WO 00/78960 (2000-12-01), None
patent: WO 01/04311 (2001-01-01), None
patent: WO 01/16289 (2001-03-01), None
patent: WO 01/23547 (2001-04-01), None
patent: WO 01/25272 (2001-04-01), None
patent: WO 01/27257 (2001-04-01), None
patent: WO 01/34802 (2001-05-01), None
patent: WO 01/51633 (2001-07-01), None
Greenbaum et al. (Genome Biology, 2003, vol. 4, Issue 9, pp. 117.1-117.8).
Fu et al 1996 (EMBO Journal, vol. 15, pp. 4392-4401).
Yokota, J et al, 1988 (Oncogene, vol. 3, pp. 471-475).
Zimmer, 1991 (Cell Motility and the Cytoskeleton, vol. 20, pp. 325-337).
Hell et al, 1995 (Laboratory Investigation, vol. 73, pp. 492-496).
Guo et al, 2002 (Journal of Pharmacology and Experimental Therapeutics, vol. 300, pp. 206-212).
Schmid S et al, 2001 (J comparative Neurology, 430(2): 160-71).
Conner et al, 1996 (Mol Brain Res, 42: 1-17).
Kibel, AS et al, 2000, J urol, 164(1): 192-6.
Dong et al, 2000, Cancer Research, 60: 3880-3883.
Zhau, HE, 1994, J Cell Biochem, Suppl 19: 208-216.
Ren, C et al, 1998, Cancer Res, 58(6): 1285-90.
Gingrich, JR et al, 1996, Cancer res, 56(18): 4096-4102.
Russo, V et al, 1995, Int J Cancer, 64: 216-221.
Vaarala et al, 2001, Intl J Cancer, 94: 705-710.
Drexler et al, 1993 (Leukemia and Lymphoma, 9:1-25).
Embleton et al, 1984 (Immunol Ser, 23:181-207).
Hsu, 1973 (in Tissue Culture Methods and Applications, Kruse and Patterson, Eds, Academic Press, NY, see abstract, p. 764).
Tian, J et al, 2004 (Physiol Genomics, 17: 170-182).
Van Dyke D L et al, 2003 (Cancer Genetics and Cytogenetics 241: 137-141).
Zaslav A L et al, 2002 (Amer J Medical Genetics 107: 174-176).
Kunkel, P, et al, 2001 (Neuro-oncology 3(2): 82-88).
Paoloni-Giacobino et al. Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3, Genomics, 1997; 44:309-320.
Pasquali et al. Changes in tissue transglutaminase activity and expression during retinoic acid-induced growth arrest and apoptosis in primary cultures of human epithelial prostate cells, J Clin Endocin & Metab. 1999;84(4):1463-1469.
Brinkmann et al:Page-1, an X chromosome-linkedGage-like gene that is expressed in normal and neoplastic prostate, testis, and uterus. PNAS, Sep. 1998;95:10757-10762.
Chen et al. Isolation and characterization ofPage-1andGage-7, JBC. Jul. 10, 1998;273(28):17618-17625.
Dannull et al. Prostate stem cell antigen is a promising candidate for Immunotherapy of advanced prostate cancer. Can. Res. Oct. 1, 2000;60(19):5323-5598.
An G, Meka CS, Bright SP, Veltri RW. Human prostate-specific transglutaminase gene: promoter cloning, tissue-specific expression, and down-regulation in metastatic prostate cancer. Urology. Dec. 1999;54(6):1105-11.
Dubbink HJ, Cleutjens KB, van der Korput HA, Trapman J, Romijn JC. An Sp1 binding site is essential for basal activity of the human prostate-specific transglutaminase gene (TGM4) promoter. Gene. Nov. 29, 1999, vol. 240(2), pp. 261-267.
An G, Meka CS, Bright SP, Veltri RW. Human prostate-specific transglutaminase gene: promoter cloning, tissue-specific expression, and down-regulation in metastatic prostate cancer. Urology. Dec. 1999;54(6):1105-11.
Dubbink,H.J., de Waal,L., van Haperen,R., Verkaik,N.S., Trapman,J. and Romijn,J.C. The human prostate-specific transglutaminase gene (TGM4): genomic organization, tissue-specific expression, and promoter characterization. Genomics, vol. 51(3), 1998, pp. 434-444.
Dubbink,H.J., Verkalk,N.S., Faber,P.W., Trapman,J., Schroder,F.H. and Romijn,J.C. Tissue specific and androgen-regulated expression of human prostate-specific transglutaminase. Biochem. J. vol. 315(Pt 3), 1996, pp. 901-908.
Gentile V, Grant FJ, Porta R and Baldini A. Localization of the human prostate transglutaminase (type IV) gene. (TGM4) to chromosome 3p21.33-p22 by fluorescence in situ hybridization. Genomics, vol. 27(1), 1995, pp. 219-220.
Goebel HW, Rausch U, Steinhoff M, Seitz J, Bacher M, Papotti M, Bussolati G, Tuohimaa P, Aumuller G. Arguments against the prostatic origin of the R-3327 Dunning H tumor. Virchows Arch B Cell Pathol Incl Mol Pathol. 1992, vol. 62(1), pp. 9-18.
Grant FJ, Taylor DA, Sheppard PO, Mathewes SL, Lint W, Vanaja E, Bishop PD and O'Hara PJ. Molecular cloning and characterization of a novel transglutaminase cDNA from a human prostate cDNA library. Biochem. Biophys. Res. Commun. vol. 203(2), 1994, pp. 1117-1123.
Bussemakers et al., “DD3:A New Prostate-specific Gene, Highly Overexpressed in Prostate Cancer1”,Cancer Research1999 59(23) :5975-5979.
Cho-Chung Y.S., “Antisense oligonucleotides for the treatment of cancer”,Curr. Opin. Thera. Patents1993 3(12):1737-1750.
Olsson et al., “Reverse Transcriptase-Polymerase Chain Reaction Assays for Prostate Cancer”,Urologic Clinics of North America1997 24(2):367-378.
Blok et al., “Isolation of cDNAs That Are Differentially Expressed Between Androgen-Dependent and Androgen-Independent Prostate Carcinoma Cells Using Differentially Disply PCR”, The Prostate 1995 26:213-224.
Chang et al., “Differentially Expressed Genes in Androgen-dependent and -independent Prostate Carcinomas1”, Cancer Research 1997 57:4075-4081.
Friedrich et al., “Differention-Stage Specific Expression of Oncoprotein 18 in Human and Rat Prostatic Adenocarcinoma”, The Prostate 1995 27:102-109.
Gagnon et al., “Expression of Zn-Alpha2-Glycoprotein and PSP-94 in Prostatic Adenocarcinoma”, American Journal of Pathology 1990 136(5):1147-1152.
Hale et al., “Zinc α-2-Glycoprotein Is Expressed by Malignant Prostatic Epithelium and May Serve as a Potential Serum Marker for Prostate Cancer1”, Clinical Cancer Research 2001 7(7):846-853.
López-Otín et al., “Breast and Prostate Cancer:An Analysis of Common Epidemiological, Genetic and Biochemical Features”, Endocrine Reviews 1998 19(4):365-396.
Olsson et al., “Reverse Transcriptase-Polymerase Chain Reaction Assays for Prostate Cancer”, Urologic Clinics of North America 1997 24(2) :367-378.
Ueyama et al., “Molecular Cloning and Chromosomal Assignment of the Gene for Human Zn-α2-glycoportein”, Biochemistry 1993 32:12968-12976.
EMB/GenBank/DDBJ XO-002220465 -Ueyama et al., “Molecular Cloning and Chromosomal Assignment of the Gene for Human Zn-α2-glycoportein”, Biochemistry
Cafferkey Robert
Recipon Herve
Salceda Susana
Davis Minh-Tam
diaDexus, Inc.
Helms Larry R.
Licata & Tyrrell P.C.
McCollum Keith R.
LandOfFree
Method of diagnosing, monitoring, staging, imaging and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of diagnosing, monitoring, staging, imaging and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of diagnosing, monitoring, staging, imaging and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3989505